Bluejay Diagnostics (BJDX) Competitors $1.31 -0.07 (-5.07%) Closing price 04:00 PM EasternExtended Trading$1.33 +0.02 (+1.53%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. LUCY, CODX, SSKN, POAI, LFWD, ICU, HSCS, AMIX, STRR, and SINTShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Innovative Eyewear (LUCY), Co-Diagnostics (CODX), Strata Skin Sciences (SSKN), Predictive Oncology (POAI), Lifeward (LFWD), SeaStar Medical (ICU), HeartSciences (HSCS), Autonomix Medical (AMIX), Star Equity (STRR), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors Innovative Eyewear Co-Diagnostics Strata Skin Sciences Predictive Oncology Lifeward SeaStar Medical HeartSciences Autonomix Medical Star Equity Sintx Technologies Innovative Eyewear (NASDAQ:LUCY) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership. Which has preferable earnings and valuation, LUCY or BJDX? Bluejay Diagnostics has lower revenue, but higher earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovative Eyewear$1.71M5.89-$7.77M-$3.99-0.55Bluejay DiagnosticsN/AN/A-$7.72M-$125.15-0.01 Do insiders and institutionals believe in LUCY or BJDX? 1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is LUCY or BJDX more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Innovative Eyewear's net margin of -443.18%. Innovative Eyewear's return on equity of -86.90% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Innovative Eyewear-443.18% -86.90% -81.36% Bluejay Diagnostics N/A -362.07%-299.10% Which has more risk & volatility, LUCY or BJDX? Innovative Eyewear has a beta of 3.21, suggesting that its share price is 221% more volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Does the media refer more to LUCY or BJDX? In the previous week, Innovative Eyewear and Innovative Eyewear both had 4 articles in the media. Innovative Eyewear's average media sentiment score of 0.97 beat Bluejay Diagnostics' score of 0.45 indicating that Innovative Eyewear is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bluejay Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryInnovative Eyewear beats Bluejay Diagnostics on 7 of the 11 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96M$6.90B$5.60B$9.82BDividend YieldN/A1.31%4.60%4.11%P/E Ratio-0.0125.2330.2825.72Price / SalesN/A68.65387.9280.32Price / CashN/A21.6737.7558.93Price / Book0.375.648.456.01Net Income-$7.72M$176.29M$3.25B$265.06M7 Day Performance-10.88%3.75%4.05%2.80%1 Month Performance-18.63%-0.67%4.32%1.68%1 Year Performance-91.16%12.97%36.25%29.59% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.6469 of 5 stars$1.31-5.1%N/A-91.7%$1.96MN/A-0.019Earnings ReportShort Interest ↑Gap DownLUCYInnovative Eyewear0.8624 of 5 stars$2.01+3.6%N/A-51.0%$8.88M$1.71M-0.509News CoverageUpcoming EarningsShort Interest ↓CODXCo-Diagnostics4.5615 of 5 stars$0.26+3.4%$5.50+2,042.6%-77.8%$8.33M$3.91M-0.22100News CoverageEarnings ReportShort Interest ↓Gap UpSSKNStrata Skin Sciences2.5635 of 5 stars$1.93-1.0%$6.00+210.9%-30.6%$8.13M$33.62M-0.85120News CoverageEarnings ReportShort Interest ↑POAIPredictive Oncology1.5744 of 5 stars$0.77+1.6%$3.00+287.6%-12.2%$7.79M$1.62M-0.2530News CoverageNegative NewsEarnings ReportLFWDLifeward2.6902 of 5 stars$0.70+0.5%$9.00+1,185.7%-77.4%$7.67M$25.66M-0.2360Trending NewsICUSeaStar Medical0.2979 of 5 stars$0.70+6.4%N/A-88.0%$7.34M$428K-0.202Earnings ReportShort Interest ↑HSCSHeartSciences3.4114 of 5 stars$3.30+8.2%$13.00+293.9%+7.0%$6.85M$4.35K-0.3510Short Interest ↓AMIXAutonomix Medical3.165 of 5 stars$1.34-3.6%$16.50+1,131.3%-91.4%$6.78MN/A-0.181News CoveragePositive NewsEarnings ReportShort Interest ↑STRRStar Equity2.9675 of 5 stars$1.99-1.5%$5.00+151.3%-38.5%$6.51M$53.36M-0.58460News CoverageAnalyst ForecastSINTSintx Technologies2.8356 of 5 stars$2.67+11.3%$28.00+948.7%-28.4%$6.02M$2.89M-0.0540Short Interest ↓Gap Up Related Companies and Tools Related Companies Innovative Eyewear Alternatives Co-Diagnostics Alternatives Strata Skin Sciences Alternatives Predictive Oncology Alternatives Lifeward Alternatives SeaStar Medical Alternatives HeartSciences Alternatives Autonomix Medical Alternatives Star Equity Alternatives Sintx Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access